Live flow imaging today. Built AI-ready.
Today's tools confirm that blood is flowing — not how it flows.
ViewFlow targets the same surgeons, same workflow, and same operating rooms as the glow dye (fluorescent) imaging — but without requiring dye injection.
5 million of 500 million surgeries use a functionally objective tool to assess adequacy of blood flow.
A rare intersection of laser physics, life science experience, and building novel visualization — guided by advisors from the nation's top surgical institutions.
Jim turns new insights into new technologies. Published in quantum dynamics as an undergraduate. Led cybersecurity and systems engineering at a Lockheed Martin national computing center. Developed an AI-ready cheminformatics platform, licensed by Merck and Roche. And now, an AI-ready surgical camera.
ViewFlow is the culmination: FDA-listed, it shows surgeons how blood flows in real time — no dyes, no contact, no radiation. The last company in this space sold to Stryker for $701M.
He has long helped others build, too: as adjunct faculty in the Duke and NC State MBA and MEM programs, including while starting ViewFlow, and as ViewFlow's sponsor, he led 30 practicums for Fortune 1000 companies and startups, and he assessed over 100 inventions for NASA and university tech transfer offices.
Engaging with leading academic medical centers to reduce patient complications and become a future standard of care.
